SCHEMBL3433131

SCHEMBL3433131

Cc1ccnc(NC(O)c2c(-c3ccc(Cl)c(Cl)c3)nc3cc(C)ccn23)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 2/20 0.41
SYK P43405 1/20 0.38
NR1H4 Q96RI1 1/20 0.37
PHGDH O43175 1/20 0.36
GAA P10253 2/20 0.36
TP53 P04637 1/20 0.36
MAPK14 Q16539 2/20 0.36
FDPS P14324 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
SORT1 Q99523 1/20 0.34
ALOX5 P09917 1/20 0.34
MAPT P10636 1/20 0.34
MITF O75030 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3396205 0.89 ALOX5 (0.44) SYKGAATP53FDPSSMN1; SMN2
SCHEMBL15879650 0.84 SMN1; SMN2 (0.43) MDM2SYKGAATP53FDPS
SCHEMBL3395698 0.83 PHGDH (0.38) MDM2SYKPHGDHGAAFDPS
SCHEMBL3388535 0.76 MAPK14 (0.35) GAATP53MAPK14SMN1; SMN2KDM4E
SCHEMBL1691404 0.70 NR1H4 (0.44) NR1H4SMN1; SMN2KDM4EALDH1A1POLB
SCHEMBL14889093 0.68 RAB9A (0.46) NR1H4SMN1; SMN2KDM4EALDH1A1POLB
SCHEMBL14632152 0.68 ALDH1A1 (0.46) GAATP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL3393141 0.65 SLC34A1 (0.33) MAPK14
SCHEMBL3363076 0.62 MAPT (0.48) NR1H4GAATP53KDM4EALDH1A1
SCHEMBL22511537 0.61 FDPS (0.60) TP53FDPSSMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP disclosed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS SSB, MIF, IDO1 MDM2 3074/4885SYK 408/4885NR1H4 3133/4885
US-20140206662-A1 Imidazopyridine Compounds SSB, NFKBIA, TPMT MDM2 2800/4885SYK 221/4885NR1H4 2743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.